EE9700302A - Meetod maania ja bipolaarse häire raviks - Google Patents

Meetod maania ja bipolaarse häire raviks

Info

Publication number: EE9700302A
Authority: EE; Estonia
Prior art keywords: bipolar disorder; treating mania; mania; treatment; treating
Prior art date: 1995-05-15

Application number

EE9700302A

Other languages

English (en)

Other versions

EE03420B1 (et

Inventor

Chandra Pande Atul

Original Assignee

Warner-Lambert Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-15

Filing date

1996-04-26

Publication date

1998-06-15

1996-04-26 Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company

1998-06-15 Publication of EE9700302A publication Critical patent/EE9700302A/et

2001-06-15 Publication of EE03420B1 publication Critical patent/EE03420B1/et

Links

208000020925 Bipolar disease Diseases 0.000 title abstract 2
206010026749 Mania Diseases 0.000 title abstract 2
UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 abstract 2
230000001154 acute effect Effects 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229960002870 gabapentin Drugs 0.000 abstract 1
230000000306 recurrent effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Psychiatry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Beans For Foods Or Fodder (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)
Pyridine Compounds (AREA)
Indole Compounds (AREA)

EE9700302A 1995-05-15 1996-04-26 Farmatseutiline kompositsioon maania ja bipolaarse häire raviks EE03420B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/440,570 US5510381A (en)	1995-05-15	1995-05-15	Method of treatment of mania and bipolar disorder
PCT/US1996/005898 WO1996036328A1 (en)	1995-05-15	1996-04-26	A method of treatment of mania and bipolar disorder

Publications (2)

Publication Number	Publication Date
EE9700302A true EE9700302A (et)	1998-06-15
EE03420B1 EE03420B1 (et)	2001-06-15

Family

ID=23749281

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EE9700302A EE03420B1 (et)	1995-05-15	1996-04-26	Farmatseutiline kompositsioon maania ja bipolaarse häire raviks

Country Status (19)

Country	Link
US (1)	US5510381A (et)
EP (1)	EP0825857B1 (et)
JP (1)	JPH11505244A (et)
AT (1)	ATE218857T1 (et)
AU (1)	AU702435B2 (et)
CA (1)	CA2215923C (et)
CZ (1)	CZ288072B6 (et)
DE (1)	DE69621799T2 (et)
DK (1)	DK0825857T3 (et)
EE (1)	EE03420B1 (et)
ES (1)	ES2177783T3 (et)
GE (1)	GEP20002014B (et)
HU (1)	HUP9802087A3 (et)
NO (1)	NO315967B1 (et)
NZ (1)	NZ307366A (et)
PT (1)	PT825857E (et)
SK (1)	SK281982B6 (et)
WO (1)	WO1996036328A1 (et)
ZA (1)	ZA963826B (et)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6372792B1 (en)	1996-04-26	2002-04-16	Guy Chouinard	Method for treating anxiety, anxiety disorders and insomnia
EP0934061B3 (en)	1996-07-24	2015-01-21	Warner-Lambert Company LLC	Isobutylgaba and its derivatives for the treatment of pain
US6294690B1 (en)	1997-10-07	2001-09-25	Warner-Lambert Company	Process for preparing a cyclic amino acid anticonvulsant compound
ATE323067T1 (de)	1997-10-27	2006-04-15	Warner Lambert Co	Zyklische aminosäuren und deren derivate als arzneimittel
WO1999059572A1 (en) *	1998-05-15	1999-11-25	Warner-Lambert Company	Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
CA2327285C (en)	1998-05-15	2005-06-14	Warner-Lambert Company	Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
JP2002516312A (ja)	1998-05-26	2002-06-04	ワーナー−ランバート・カンパニー	カルシウムチャンネルのα２δサブユニットに対する親和性を有する立体配座的に制約されたアミノ酸化合物
BR9911887A (pt) *	1998-07-09	2001-03-27	Warner Lambert Co	Método para o tratamento da insÈnia
WO2000023067A1 (en) *	1998-10-16	2000-04-27	Warner-Lambert Company	Method for the treatment of mania and bipolar disorder
JP2003525207A (ja)	1999-06-02	2003-08-26	ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー	薬剤として有用なアミノ複素環
AP2002002501A0 (en) *	1999-10-07	2002-06-30	Warner Lambert Co	Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
CA2411787C (en) *	2000-06-16	2007-03-20	Teva Pharmaceuticals Industries Ltd.	Stable gabapentin having ph within a controlled range
NZ522480A (en) *	2000-06-26	2005-06-24	Warner Lambert Co	Gabapentin analogues for sleep disorders
US20030119908A1 (en) *	2001-12-21	2003-06-26	Zambon Group S.P.A.	Stable gabapentin compositions
ITMI20012750A1 (it)	2001-12-21	2003-06-21	Procos Spa	Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura
CA2451267A1 (en) *	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
EP2575798B1 (en)	2010-06-01	2017-08-09	Rubicon Research Private Limited	Gastroretentive dosage forms of gaba analogs
WO2015144825A1 (en)	2014-03-27	2015-10-01	Sanovel Ilac Sanayi Ve Ticaret A.S.	Oral liquid pharmaceutical solution of gabapentin
US11670410B1 (en) *	2022-04-13	2023-06-06	Green Sky Creations LLC	Systems and methods to automatically administer a psychoactive substance to an airway of a user based on a detected event or condition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2460891C2 (de) *	1974-12-21	1982-09-23	Gödecke AG, 1000 Berlin	1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) *	1974-12-21	1978-05-02	Warner-Lambert Company	Treatment of cranial dysfunctions using novel cyclic amino acids
US4355044A (en) *	1980-12-19	1982-10-19	Bernardo Heller	D-Phenylalanine treatment
US5084479A (en) *	1990-01-02	1992-01-28	Warner-Lambert Company	Novel methods for treating neurodegenerative diseases
US5086072A (en) *	1990-06-18	1992-02-04	The United States Of America As Represented By The Department Of Health And Human Services	Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
US5025035A (en) *	1990-10-12	1991-06-18	Warner-Lambert Company	Method of treating depression

1995
- 1995-05-15 US US08/440,570 patent/US5510381A/en not_active Expired - Fee Related
1996
- 1996-04-26 AU AU56689/96A patent/AU702435B2/en not_active Ceased
- 1996-04-26 DE DE69621799T patent/DE69621799T2/de not_active Expired - Fee Related
- 1996-04-26 JP JP8534854A patent/JPH11505244A/ja not_active Ceased
- 1996-04-26 AT AT96913852T patent/ATE218857T1/de not_active IP Right Cessation
- 1996-04-26 GE GEAP19964027A patent/GEP20002014B/en unknown
- 1996-04-26 CA CA002215923A patent/CA2215923C/en not_active Expired - Fee Related
- 1996-04-26 SK SK1528-97A patent/SK281982B6/sk unknown
- 1996-04-26 EP EP96913852A patent/EP0825857B1/en not_active Expired - Lifetime
- 1996-04-26 DK DK96913852T patent/DK0825857T3/da active
- 1996-04-26 EE EE9700302A patent/EE03420B1/et not_active IP Right Cessation
- 1996-04-26 WO PCT/US1996/005898 patent/WO1996036328A1/en not_active Ceased
- 1996-04-26 CZ CZ19973558A patent/CZ288072B6/cs not_active IP Right Cessation
- 1996-04-26 NZ NZ307366A patent/NZ307366A/en unknown
- 1996-04-26 ES ES96913852T patent/ES2177783T3/es not_active Expired - Lifetime
- 1996-04-26 HU HU9802087A patent/HUP9802087A3/hu unknown
- 1996-04-26 PT PT96913852T patent/PT825857E/pt unknown
- 1996-05-14 ZA ZA963826A patent/ZA963826B/xx unknown
1997
- 1997-11-14 NO NO19975234A patent/NO315967B1/no unknown

Also Published As

Publication number	Publication date
NO975234L (no)	1997-11-14
US5510381A (en)	1996-04-23
AU702435B2 (en)	1999-02-18
JPH11505244A (ja)	1999-05-18
CA2215923C (en)	2001-10-09
SK281982B6 (sk)	2001-09-11
ATE218857T1 (de)	2002-06-15
SK152897A3 (en)	1999-05-07
DK0825857T3 (da)	2002-09-30
MX9707269A (es)	1997-11-29
CA2215923A1 (en)	1996-11-21
ZA963826B (en)	1996-11-21
DE69621799T2 (de)	2003-01-02
PT825857E (pt)	2002-11-29
CZ355897A3 (cs)	1998-02-18
AU5668996A (en)	1996-11-29
WO1996036328A1 (en)	1996-11-21
NZ307366A (en)	1999-10-28
NO975234D0 (no)	1997-11-14
NO315967B1 (no)	2003-11-24
CZ288072B6 (cs)	2001-04-11
DE69621799D1 (de)	2002-07-18
EE03420B1 (et)	2001-06-15
HUP9802087A3 (en)	1999-08-30
EP0825857A1 (en)	1998-03-04
EP0825857B1 (en)	2002-06-12
GEP20002014B (en)	2000-04-10
HUP9802087A2 (hu)	1998-12-28
ES2177783T3 (es)	2002-12-16

Legal Events

Date	Code	Title	Description
2003-02-17	KB4A	Valid patent at the end of a year	Effective date: 20021231
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2006-02-15	KB4A	Valid patent at the end of a year	Effective date: 20051231
2007-02-15	KB4A	Valid patent at the end of a year	Effective date: 20061231
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2008-12-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20080426

Publication	Publication Date	Title
EE03420B1 (et)	2001-06-15	Farmatseutiline kompositsioon maania ja bipolaarse häire raviks
CA2344407A1 (en)	2000-04-27	Method for the treatment of mania and bipolar disorder
DE69829112D1 (de)	2005-03-31	Butyrate derivaten zur behandlung von fibromyalgia und chronische müdigkeit-syndrom
DE3687099D1 (de)	1992-12-17	Verwendung von einem cartilago-induzierenden faktor (cif) zur herstellung eines arzneimittels zur behandlung von entzuendungen.
ATE241351T1 (de)	2003-06-15	Isobutylgaba und dessen derivate zur schmerzbehandlung
DK0668763T3 (da)	2002-06-03	Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme
DE69631478D1 (de)	2004-03-11	Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE275966T1 (de)	2004-10-15	Activin stimulator enthaltende pharmazeutische zusammensetzung
BR9814419A (pt)	2000-10-10	"combinação de compostos de benzociclo-heptapiridina e drogas antineopláticas para tratamento de doenças proliferativas"
DE69201660D1 (de)	1995-04-20	Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma.
YU42298A (sh)	1999-09-27	Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
RU94041028A (ru)	1996-09-20	Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
MD1716C2 (ro)	2002-02-28	Utilizare a melatoninei pentru tratamentul pacienţilor dependenţi de benzodiazepine
NO984197D0 (no)	1998-09-11	Fremgangsmåte for behandling av autisme
DE69300037D1 (de)	1995-02-09	Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
BR9701455A (pt)	1998-08-18	Uso de antagonistas de bradicinina para a preparaçao de medicamentos para o tratamento de doenças fibrogenéticas crônicas do fígado e doenças agudas do fígado
NO953003L (no)	1996-01-30	Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
BR9801839A (pt)	2000-01-18	Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
YU40098A (sh)	1999-09-27	Upotreba olanzapina za dobijanje leka
ES2139382T3 (es)	2000-02-01	Sistema terapeutico percutaneo para compuestos de silatran.
UA22009A (uk)	1998-04-30	Спосіб лікуваhhя сальпіhгоофориту
DE59712215D1 (de)	2005-04-07	Transdermales therapeutisches system mit einer östriol enthaltenden bisphosphatekombination
EA199800820A1 (ru)	1999-02-25	Способ лечения злоупотребления лекарственными средствами
UA8280A (uk)	1996-03-29	Спосіб лікування псоріазу
MX9801515A (es)	1998-08-30	Preparado de combinacion para la aplicacion en la demencia.